Margaret Tooth Sells 1,000 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $25.00, for a total value of $25,000.00. Following the completion of the transaction, the chief executive officer directly owned 185,952 shares in the company, valued at approximately $4,648,800. This trade represents a 0.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Margaret Tooth also recently made the following trade(s):

• On Tuesday, August 25th, Margaret Tooth sold 491 shares of Trupanion stock. The stock was sold at an average price of $31.84, for a total value of $15,633.44.
• On Tuesday, August 11th, Margaret Tooth sold 978 shares of Trupanion stock. The stock was sold at an average price of $29.05, for a total transaction of $28,410.90.

Trupanion Stock Performance

NASDAQ:TRUP opened at $25.63 on Thursday. The company has a fifty day moving average of $27.36 and a 200-day moving average of $25.76. The firm has a market capitalization of $1.12 billion, a P/E ratio of 48.36, a P/E/G ratio of 1.78 and a beta of 1.45. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. Trupanion, Inc. has a twelve month low of $21.16 and a twelve month high of $46.98.

Trupanion (NASDAQ:TRUP) last issued its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.05. The business had revenue of $392.93 million for the quarter, compared to analyst estimates of $389.72 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. Trupanion’s revenue was up 11.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.22 earnings per share. As a group, sell-side analysts anticipate that Trupanion, Inc. will post 0.63 EPS for the current year.

Institutional Investors Weigh In On Trupanion

A number of institutional investors and hedge funds have recently made changes to their positions in TRUP. BlackRock Inc. purchased a new position in Trupanion during the second quarter worth about $134,774,000. Bank of America Corp DE purchased a new stake in Trupanion in the 2nd quarter valued at about $14,262,000. Renaissancere Holdings Ltd. bought a new position in shares of Trupanion during the 2nd quarter worth approximately $6,514,510. Bank of New York Mellon Corp bought a new position in shares of Trupanion during the 2nd quarter worth approximately $4,631,000. Finally, Polar Capital Holdings Plc boosted its stake in shares of Trupanion by 13.5% in the 4th quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider’s stock worth $55,121,000 after buying an additional 175,000 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Piper Sandler downgraded Trupanion from an “overweight” rating to a “neutral” rating and reduced their target price for the company from $45.00 to $32.00 in a research note on Wednesday, August 26th. Zacks Research cut Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 24th. Atlantic Securities set a $42.00 price objective on Trupanion in a report on Wednesday, July 15th. Stifel Nicolaus upped their target price on Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research report on Thursday, August 20th. Finally, Weiss Ratings cut Trupanion from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday, September 10th. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $39.20.

Trupanion Company Profile

Trupanion, Inc is a pet insurance company that provides medical coverage for cats and dogs. Its subscription-based policies are designed to help pet owners manage the cost of eligible veterinary care, including coverage for unexpected illnesses and injuries. Depending on the policy and jurisdiction, coverage may include diagnostic tests, surgeries, hospital stays and prescription medications, subject to applicable terms, exclusions and deductibles.

The company also develops technology intended to simplify the relationship between pet owners, veterinarians and insurers.